(Q43538691)

24 November 2017

The effect of infections on the mortality of cirrhotic patients with hepatic encephalopathy (English)

1 reference

24 November 2017

0 references

T H Hung

1

1 reference

24 November 2017

C J Lay

2

1 reference

24 November 2017

C M Chang

3

1 reference

24 November 2017

J J Tsai

4

1 reference

24 November 2017

C C Tsai

5

1 reference

24 November 2017

C C Tsai

6

1 reference

24 November 2017

22 February 2013

1 reference

Epidemiology and Infection

24 November 2017

1 reference

24 November 2017

141

1 reference

24 November 2017

12

1 reference

24 November 2017

2671-2678

1 reference

Risk factors for hepatic encephalopathy in patients with cirrhosis and refractory ascites: relevance of serum sodium concentration.

24 November 2017

1 reference

https://api.crossref.org/works/10.1017%2FS0950268813000186

Non-adherence to antibiotic prescription guidelines in treating urinary tract infection of children: a population-based study in Taiwan.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0950268813000186

The epidemiology of sepsis in the United States from 1979 through 2000

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0950268813000186

Late admission to the ICU in patients with community-acquired pneumonia is associated with higher mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0950268813000186

Sepsis in cirrhosis: report on the 7th meeting of the International Ascites Club.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0950268813000186

Theories of the pathogenesis of hepatic encephalopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0950268813000186

Prevalence of subclinical hepatic encephalopathy in cirrhotic patients in China

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0950268813000186

Infections in patients with cirrhosis increase mortality four-fold and should be used in determining prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0950268813000186

Severe sepsis in cirrhosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0950268813000186

Persistence of cognitive impairment after resolution of overt hepatic encephalopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0950268813000186

Bacterial infection in patients with advanced cirrhosis: a multicentre prospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0950268813000186

Role of ammonia and inflammation in minimal hepatic encephalopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0950268813000186

Infection and systemic inflammation, not ammonia, are associated with Grade 3/4 hepatic encephalopathy, but not mortality in cirrhosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0950268813000186

Pathogenetic mechanisms of hepatic encephalopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0950268813000186

Incidence, natural history, and risk factors of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt with polytetrafluoroethylene-covered stent grafts

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0950268813000186

Septic acute kidney injury: hemodynamic syndrome, inflammatory disorder, or both?

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0950268813000186

Lung injury and recovery in a murine model of unilateral acid aspiration: functional, biochemical, and morphologic characterization

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0950268813000186

Hydrochloric acid aspiration increases right ventricular systolic pressure in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0950268813000186

Functional contribution of CXCR2 to lung injury after aspiration of acid and gastric particulates

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0950268813000186

Aspiration pneumonitis and aspiration pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0950268813000186

Neuropsychiatric dysfunction in patients with chronic hepatitis and liver cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0950268813000186

7 January 2021

Effects of oral branched-chain amino acid granules on event-free survival in patients with liver cirrhosis

1 reference

https://api.crossref.org/works/10.1017%2FS0950268813000186

7 January 2021

Complications of cirrhosis. II. Renal and circulatory dysfunction. Lights and shadows in an important clinical problem

1 reference

https://api.crossref.org/works/10.1017%2FS0950268813000186

7 January 2021

Predictors of mortality in hepatic encephalopathy in acute and chronic liver disease: a preliminary observation

1 reference

https://api.crossref.org/works/10.1017%2FS0950268813000186

7 January 2021

Hepatitis-B surface antigen and hepatocellular carcinoma in Taiwan. With special reference to types and localization of HBsAg in the tumor cells

1 reference

https://api.crossref.org/works/10.1017%2FS0950268813000186

7 January 2021

Ammonia and inflammation in the pathogenesis of hepatic encephalopathy: Pandora's box?

1 reference

https://api.crossref.org/works/10.1017%2FS0950268813000186

7 January 2021

Analysis of progression in risk, injury, failure, loss, and end-stage renal disease classification on outcome in patients with severe sepsis and septic shock

1 reference

https://api.crossref.org/works/10.1017%2FS0950268813000186

7 January 2021

10.1017/S0950268813000186

Identifiers

DOI

1 reference

24 November 2017

1 reference